Further to our letter dated 14th October, 2025 and in compliance with Regulation 30 read with Schedule III and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ( SEBI Listing Regulations, 2015 ) we hereby inform you that, the Board of Directors of the Company at their meeting held today viz. Thursday, 6th November, 2025, considered the following:1. Approved the Un-audited Standalone and Consolidated Financial Results for the Quarter and Half Year ended 30th September, 2025. 2. Recommended to the Shareholders following resolutions by way of Postal Ballot:a) To approve continuation of directorship of Ms. Madhu Dubhashi (DIN: 00036846) as a Non-executive Independent Director of the Company, consequent to her attaining the age of 75 years w.e.f. 6th February, 2026 up to the expiry of her current term i.e.,19th February, 2026.b) To approve re-appointment of Mr. Keval Navinchandra Doshi (DIN: 03635213), as a Non-executive Independent Director of the Company for second term of 5 (five) consecutive years w.e.f. 6th February 2026 up to 5th February 2031.c) To approve appointment of Mr. Raj Kamal (DIN: 01083088), as a Non-executive Independent Director of the Company for a period of 5 (five) years commencing from 6th November 2025 to 5th November 2030.d) To approve appointment of Ms. Pallavi Gokhale (DIN: 00036369) as a Non-executive Independent Director of the Company for period of 5 (five) years commencing from 6th November 2025 to 5th November 2030.e) To approve change in the designation of Mr. Ashok Ramnarayan Boob (DIN: 00410740), from Managing Director to Whole Time Director Executive Vice Chairman w.e.f. from 1st April, 2026 up to 27th July, 2027.f) To approve change in the designation of Mr. Siddhartha Ashok Sikchi (DIN: 02351154), from Whole Time Director to Managing Director of the Company w.e.f. from 1st April, 2026 up to 31st March, 2031.
CLEAN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors met on 6th November 2025 and approved the unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2025. The Board also recommended shareholder approval via postal ballot for a series of board changes including continuation of Ms. Madhu Dubhashi as an Independent Director until 19th February 2026, re-appointment of Mr. Keval Doshi for a second 5-year term, and appointment of two new Independent Directors — Mr. Raj Kamal and Ms. Pallavi Gokhale — each for a 5-year term. In a key leadership succession move, Mr. Ashok Boob will move from Managing Director to Whole Time Director & Executive Vice Chairman effective 1st April 2026, while Mr. Siddhartha Sikchi will be elevated from Whole Time Director to Managing Director for a term ending 31st March 2031.
The financial results are routine and their impact will depend on the actual numbers versus expectations, which are not disclosed here. The board changes signal a planned leadership succession with the current Managing Director moving to an Executive Vice Chairman role, providing continuity while a new Managing Director takes over. New independent director appointments strengthen the board's independent composition ahead of the new fiscal year.